We are live on ! Find out more
EXOZ

eXoZymes Inc
EXOZ

9 hedge funds and large institutions have $1.05M invested in eXoZymes Inc in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

122% more capital invested

Capital invested by funds: $472K → $1.05M (+$576K)

29% more funds holding

Funds holding: 7 → 9 (+2)

0.72% more ownership

Funds ownership: 0.75% → 1.47% (+0.72%)

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
+$309K
2
DKCM
Davidson Kahn Capital Management
California
+$236K
3
BlackRock
BlackRock
New York
+$26.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$14.3K
5
UBS Group
UBS Group
Switzerland
+$1.69K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$9.13K

EXOZ Hedge Fund Activity: Q2 2026 in Review

9 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in eXoZymes Inc (EXOZ) for Q2 2026, worth a combined $1.05M — up 122% from $472K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new EXOZ positions and 0 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Capital Management, adding an estimated $309K. The largest seller was Tower Research Capital (TRC), cutting an estimated $9.13K.

  • 9 institutional investors held eXoZymes Inc (EXOZ) as of Q2 2026, up from 7 in Q1 2026.
  • Funds reported $1.05M of eXoZymes Inc stock for Q2 2026, up 122% quarter-over-quarter.
  • 2 funds opened new eXoZymes Inc positions in Q2 2026 and 0 closed out, a net change of +2 holders.
  • The largest eXoZymes Inc buyer in Q2 2026 was Vanguard Capital Management, an estimated $309K added.
  • The largest eXoZymes Inc seller in Q2 2026 was Tower Research Capital (TRC), an estimated $9.13K sold.

Based on aggregated 13F filings for Q2 2026.